Additional Milestone Payments. Should the Parties agree to develop the Six Month Product, Sanofi-Synthelabo shall pay to Atrix, as licensing fees, the following milestone payments within thirty (30) days after Atrix gives notice to Sanofi-Synthelabo of the occurrence of the specified milestone event: (i) [**] (ii) [**] provided however, [**] shall be credited against [**] and [**], if any, shall be credited against amounts owed by Sanofi-Synthelabo to Atrix as set forth in Section 4.04(ii). ---------- ** Confidential Treatment Requested.
Appears in 1 contract
Sources: Collaboration, License and Supply Agreement (Atrix Laboratories Inc)
Additional Milestone Payments. Should the Parties agree to develop the Six Month Product, Sanofi-Synthelabo shall pay to Atrix, as licensing fees, the following milestone payments within thirty (30) days after Atrix gives notice to Sanofi-Synthelabo of the occurrence of the specified milestone event:
(i) [**]
(ii) [**] provided however, [**] shall be credited against [**] and [**], if any, shall be credited against amounts owed by Sanofi-Synthelabo to Atrix as set forth in Section 4.04(ii). ---------- ** Confidential Treatment Requested.
Appears in 1 contract
Sources: Collaboration, License and Supply Agreement (QLT Inc/Bc)